Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Namsos
Clinical trial register · Norway

Clinical Trials in Namsos, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Norway and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1259 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
1259
Studies in scope
all four open statuses
666
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
Oslo 727 Bergen 323 Trondheim 255 Tromsø 148 Stavanger 123

Trials with a site in Namsos

8 of 1259 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Norway
Start
Recruiting
Mother and Offspring's Nutritional Status -Pregnancy After Maternal Bariatric Surgery
NCT07877233Bariatric Surgery, Pregnency, Reproductive Health and Childbirth, Pregnancy and Delivery
Helse Nord-Trøndelag HF
Observational
210
Ålesund, Namsos, Trondheim
2025-12-25
Recruiting
Helse Nord-Trøndelag HF
Not applicable
300
Namsos
2025-10-17
Recruiting
Evaluation of the Invest in Play Program - a New Parent Intervention for Children With Problem Behavior
NCT06984809Problem Behavior, Attention Deficit and Disruptive Behavior Disorders
University of Tromso
Not applicable
180
Bergen, Haugesund, Namsos, Oslo
2025-09-25
Recruiting
Personalized Training for People With Rare Neuromuscular Disorders
NCT06708468Neuromuscular Diseases (NMD), Charcot Marie Tooth Disease (CMT), Facioscapulohumeral Muscular Dystrophy, Myotonic Dystrophy Type 1 (DM1)
Oslo University Hospital
Not applicable
120
Bergen, Molde, Namsos, Oslo, Tromsø
2024-12-13
Active, closed
Haukeland University Hospital
Phase 3
214
Bergen, Bodø, Drammen, Kristiansand, Molde, Namsos, Oslo, Skien
2020-11-02
Active, closed
Coronary CT Angiography in Non ST-elevation Myocardial Infarction
NCT04537741Non-ST Elevated Myocardial Infarction
St. Olavs Hospital
Not applicable
300
Ålesund, Kristiansund, Levanger, Molde, Namsos, Orkdal, Trondheim, Volda
2020-10-24
Active, closed
MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway
NCT03962127Stroke, Cardiovascular Diseases, Cardiovascular Risk Factor, Brain Ischemia
Norwegian University of Science and Technology
Observational
800
Ålesund, Kristiansund, Levanger, Molde, Namsos, Orkanger, Trondheim, Volda
2015-05-01
Active, closed
Norwegian University of Science and Technology
Not applicable
177
Ålesund, Bergen, Drammen, Førde, Gjøvik, Haugesund, Levanger, Namsos
2014-07-08
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Norwegian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-norway/city/namsos

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Norway and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,259 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Namsos.

How many clinical trials are recruiting in Namsos?

4 of the 8 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Namsos), 8 studies
PhaseStudiesRecruitingShare
Not applicable5362.5%
Observational2125%
Phase 31012.5%

Most active sponsors

Lead sponsors with the most studies (Namsos)
Lead sponsorStudiesRecruiting
Helse Nord-Trøndelag HF22
Norwegian University of Science and Technology20
Haukeland University Hospital10
Oslo University Hospital11
St. Olavs Hospital10
University of Tromso11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.